Search for Clinical Trial Results

Sponsored By

Purpura, Thrombocytopenic - 15 Studies Found

Status Study
Completed Study Name: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Date: 2007-01-17
Interventions: Drug: eltrombopag experimental
Completed Study Name: A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Date: 2010-03-25
Interventions: Drug: Eltrombopag olamine Thrombopoietin receptor agonist
Completed Study Name: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2015-03-20
Interventions: Drug: Hetrombopag Olamine Hetrombopag Olamine 2.5mg, 5mg and 7.5mg
Terminated Study Name: Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2013-12-09
Interventions: Drug: BI 655064 subcutaneous injection
Completed Study Name: An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Condition:
  • Purpura, Thrombocytopenic, Idiopathic
  • Immune
  • Idiopathic Thrombocytopenic Purpura
  • Purpu
    Date: 2009-01-22
    Interventions: Drug: Eltrombopag oral tablets Eltrombopag oral tablets once daily
Completed Study Name: Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2000-05-02
Interventions: Drug: rituximab
Completed Study Name: Efficacy and Safety of IVIG-L in ITP Patients
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2005-09-08
Interventions: Drug: IVIG-L
Completed Study Name: Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
Condition: Purpura, Thrombocytopenic, Idiopathic
Date: 2005-09-13
Interventions: Drug: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified IGIV-C 10% at a dose of 1.0g/kg
Completed Study Name: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Date: 2005-02-01
Interventions: Drug: SB497115
Next >>>